Biovyn PVC to be used in sustainable prosthetics for the first time
Fillauer recently announced the launch of the first-ever bio-attributed prosthetic foot shell
Fillauer recently announced the launch of the first-ever bio-attributed prosthetic foot shell
The complexity of operating on a one-year-old are many with the organs being tiny, fragile
Opinion granted based on positive disease-free survival results from the Phase 3 KEYNOTE-091 trial
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
The state-of-the-art digital PETCT imaging system, highlights a significant advancement in the fight against cancer and detects other lesions offering patient centric services
This study showed that patients taking 75mg of Olpasiran previously every 12 weeks presented a 40–50% reduction in LP(a)
This indigenously developed enhanced care technology is designed to continuously monitor and detect early signs of deterioration in a patient's condition
Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
Subscribe To Our Newsletter & Stay Updated